US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

38.69

+0.84002.22%

Volume:1.33M

Turnover:51.77M

Market Cap:5.20B

PE:-11.11

High:39.75

Open:38.83

Low:38.02

Close:37.85

52wk High:49.70

52wk Low:8.77

Shares:134.37M

Float Shares:129.77M

Volume Ratio:0.39

T/O Rate:1.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4823

EPS(LYR):-2.0600

ROE:-64.09%

ROA:-20.64%

PB:5.66

PE(LYR):-18.78

Loading ...

Overview Company News Filings

Definium Therapeutics (DFTX) Following Russell Index Removal And The Fair Value Debate

Simply Wall St.

Definium Therapeutics Issues Inducement Stock Options for 169,740 Shares to New Hires

LSD Therapy Biotech Definium Fends Off Trade-secret Lawsuit

Movement Alert｜Definium Therapeutics Falls 5.02% in Regular Trading, Trading at $44.52

Definium Therapeutics is Maintained at Buy by Canaccord Genuity

Movement Alert｜Definium Therapeutics Rises 5.04% in Regular Trading, Buoyed by Phase 3 Success and $805M Offering Completion

Wall Street Analysts Are Bullish on Top Healthcare Picks

Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

THOMSON REUTERS

Definium Therapeutics Closes USD 805 Million Upsized Follow-on Offering at USD 34 Per Share

Movement Alert｜Definium Therapeutics Rises 9.07% in Regular Trading, Phase 3 EMERGE Study Hits Primary Endpoint and $700 Million Offering Priced

Definium Therapeutics Announces Major Public Equity Offering

Definium Therapeutics is Maintained at Buy by Jones Trading

Definium Therapeutics rises 17.7%

Movement Alert｜Definium Therapeutics Rises 15.48% in Regular Trading, Trading at $42.495

Definium Therapeutics Soars Again After Upsized $700 Mln Equity Raise

Definium Therapeutics 20.6M share Secondary priced at $34.00

Definium Therapeutics price target raised to $74 from $61 at JonesResearch

BRIEF-Definium Prices Offering Of 20.59 Million Shares At $34/Share

Definium Therapeutics prices upsized public offering at USD 700 million

Definium Therapeutics - Prices Public Offering of 20.59 Mln Shares at $34 per Share

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/DFTX/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":38.69,"timestamp":1789675026674,"preClose":37.85,"halted":0,"volume":1332691,"delay":0,"changeRate":0.02219286657859964,"floatShares":129766311,"shares":134366950,"eps":-3.482311,"marketStatus":"Trading","change":0.84,"latestTime":"09-17 15:57:07 EDT","open":38.83,"high":39.745,"low":38.02,"amount":51765587.241973,"amplitude":0.045575,"askPrice":38.72,"askSize":627,"bidPrice":38.69,"bidSize":392,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":37.85,"preHourTrading":{"tag":"盘前","latestPrice":38.64,"preClose":37.85,"latestTime":"09:29 EDT","volume":5668,"amount":217998.47836,"timestamp":1789651799999,"change":0.79,"changeRate":0.020872,"amplitude":0.022721},"postHourTrading":{"tag":"盘后","latestPrice":37.96,"preClose":37.85,"latestTime":"19:59 EDT","volume":354011,"amount":13399804.4435,"timestamp":1789603150319,"change":0.11,"changeRate":0.002906,"amplitude":0.024835},"volumeRatio":0.393001,"impliedVol":0.6366,"impliedVolPercentile":0.0119},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":129766311,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":0.393001,"shares":134366950,"dividePrice":0,"high":39.745,"amplitude":0.045575,"preClose":37.85,"low":38.02,"week52Low":8.7732,"pbRate":"5.66","week52High":49.7,"institutionHeld":0,"latestPrice":38.69,"committee":-0.230618,"eps":-3.482311,"divideRate":0,"volume":1332691,"delay":0,"ttmEps":-3.482311,"open":38.83,"prevYearClose":13.39,"prevWeekClose":38.89,"prevMonthClose":39.72,"prevQuarterClose":47.04,"fiveDayClose":37.73,"twentyDayClose":45.82,"sixtyDayClose":36.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787025600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-09-16","current":-11.104695,"percent":0.349398,"low":-27.074722,"twenty":-17.23221,"median":-11.217823,"eighty":-9.909647,"high":-8.802064,"avg":-13.946372,"sd":5.354921,"marketCap":4947391099},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530},{"date":"2026-08-28","current":-16.642763,"twenty":-17.426666,"median":-11.092954,"eighty":-9.887379,"marketCap":5887959749},{"date":"2026-09-04","current":-14.432336,"twenty":-17.33018,"median":-11.139168,"eighty":-9.901443,"marketCap":5105944100},{"date":"2026-09-11","current":-14.329791,"twenty":-17.27056,"median":-11.195675,"eighty":-9.903787,"marketCap":5069665023},{"date":"2026-09-16","current":-13.984174,"twenty":-17.23221,"median":-11.217823,"eighty":-9.909647,"marketCap":4947391099}],"updateTime":1789653503751},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649529958","title":"Definium Therapeutics (DFTX) Following Russell Index Removal And The Fair Value Debate","url":"https://stock-news.laohu8.com/highlight/detail?id=2649529958","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649529958?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:42","pubTimestamp":1783456965,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) has attracted fresh attention after being removed from several Russell indexes, a shift that can influence index linked trading, liquidity, and how some investors view the stock.\nSee our latest analysis for Definium Therapeutics.\nDespite the index removals and recent inducement grants, Definium Therapeutics has seen strong momentum build over recent months, with a 30 day share price return of 88.24%, a 90 day share price return of 115.40% and a year to date share...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/definium-therapeutics-dftx-following-russell-index-removal-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/definium-therapeutics-dftx-following-russell-index-removal-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679972","title":"Definium Therapeutics Issues Inducement Stock Options for 169,740 Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679972","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679972?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:01","pubTimestamp":1783368080,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issues inducement stock options for 169,740 shares to new hiresDefinium Therapeutics issued inducement stock options covering 169,740 common shares to eight newly hired non-execu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL72SgMh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648547239","title":"LSD Therapy Biotech Definium Fends Off Trade-secret Lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2648547239","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648547239?lang=en_us&edition=fundamental","pubTime":"2026-07-02 00:51","pubTimestamp":1782924663,"startTime":"0","endTime":"0","summary":"LSD therapy biotech Definium fends off trade-secret lawsuitJuly 1 (Reuters)-Psychedelic therapy developer Definium TherapeuticsDFTX.Oconvinced a federal judge in Delaware on Wednesday to dismiss a law","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nL6N43312L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110488888","title":"Movement Alert｜Definium Therapeutics Falls 5.02% in Regular Trading, Trading at $44.52","url":"https://stock-news.laohu8.com/highlight/detail?id=1110488888","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110488888?lang=en_us&edition=fundamental","pubTime":"2026-07-01 23:51","pubTimestamp":1782921060,"startTime":"0","endTime":"0","summary":"On July 1, Definium Therapeutics fell 5.02% in regular trading, trading at $44.52 USD/share, with Turnover of $43.21 million.Within the Pharmacy sector where Definium Therapeutics belongs, among...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647550271","title":"Definium Therapeutics is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2647550271","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647550271?lang=en_us&edition=fundamental","pubTime":"2026-06-30 23:34","pubTimestamp":1782833640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings(END) Dow Jones NewswiresJune 30, 2026 11:34 ET","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121673904","title":"Movement Alert｜Definium Therapeutics Rises 5.04% in Regular Trading, Buoyed by Phase 3 Success and $805M Offering Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=1121673904","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121673904?lang=en_us&edition=fundamental","pubTime":"2026-06-30 22:04","pubTimestamp":1782828274,"startTime":"0","endTime":"0","summary":"On June 30, Definium Therapeutics rose 5.04% in regular trading, trading at $48.63 per share, with turnover of $22.16 million. The rally follows a cluster of positive catalysts in recent sessions.On...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646397771","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2646397771","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646397771?lang=en_us&edition=fundamental","pubTime":"2026-06-27 22:30","pubTimestamp":1782570614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Definium Therapeutics (DFTX) and Eledon Pharmaceutic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-236?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-236?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646385769","title":"Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2646385769","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646385769?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:24","pubTimestamp":1782419085,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nFWN42X0QO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646129385","title":"Definium Therapeutics Closes USD 805 Million Upsized Follow-on Offering at USD 34 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2646129385","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646129385?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:15","pubTimestamp":1782418541,"startTime":"0","endTime":"0","summary":"Definium Therapeutics closes USD 805 million upsized follow-on offering at USD 34 per shareDefinium Therapeutics closed an upsized underwritten public offering of 23,676,471 common shares at USD 34 pe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDLcfdgfY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100061988","title":"Movement Alert｜Definium Therapeutics Rises 9.07% in Regular Trading, Phase 3 EMERGE Study Hits Primary Endpoint and $700 Million Offering Priced","url":"https://stock-news.laohu8.com/highlight/detail?id=1100061988","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100061988?lang=en_us&edition=fundamental","pubTime":"2026-06-25 22:26","pubTimestamp":1782397592,"startTime":"0","endTime":"0","summary":"On June 25, Definium Therapeutics rose 9.07% in regular trading, trading at $45.455/share, with turnover of approximately $98.63 million. The stock continued its momentum driven by multiple positive...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646284904","title":"Definium Therapeutics Announces Major Public Equity Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2646284904","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646284904?lang=en_us&edition=fundamental","pubTime":"2026-06-25 05:27","pubTimestamp":1782336451,"startTime":"0","endTime":"0","summary":"The latest update is out from Definium Therapeutics ( ($DFTX) ). On June 23, 2026, Definium Therapeutics, Inc. entered into an underwriting agreeme...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-announces-major-public-equity-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-announces-major-public-equity-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","EQR","DFTX","BK4007","BK4215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646281070","title":"Definium Therapeutics is Maintained at Buy by Jones Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2646281070","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646281070?lang=en_us&edition=fundamental","pubTime":"2026-06-25 02:29","pubTimestamp":1782325740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings(END) Dow Jones NewswiresJune 24, 2026 14:29 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645819648","title":"Definium Therapeutics rises 17.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645819648","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645819648?lang=en_us&edition=fundamental","pubTime":"2026-06-24 22:05","pubTimestamp":1782309951,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) is up 17.7%, or $6.40 to $42.58. Published first on TheFly – the ultimate source for real-time, market-moving breaking...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-rises-17-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-rises-17-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166167066","title":"Movement Alert｜Definium Therapeutics Rises 15.48% in Regular Trading, Trading at $42.495","url":"https://stock-news.laohu8.com/highlight/detail?id=1166167066","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166167066?lang=en_us&edition=fundamental","pubTime":"2026-06-24 22:01","pubTimestamp":1782309693,"startTime":"0","endTime":"0","summary":"On June 24, Definium Therapeutics rose 15.48% in regular trading, trading at $42.495/share, with Turnover of $157 million.Within the Pharmacy sector where Definium Therapeutics belongs, the overall...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645581611","title":"Definium Therapeutics Soars Again After Upsized $700 Mln Equity Raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2645581611","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645581611?lang=en_us&edition=fundamental","pubTime":"2026-06-24 21:56","pubTimestamp":1782309374,"startTime":"0","endTime":"0","summary":"BUZZ-Definium Therapeutics soars again after upsized $700 mln equity raise** Definium Therapeutics;DFTX.Oshares up 16.1% to $42 in early Weds trading after above-target $700 mln haul** DFTX late Tues announced pricing ~20.6 mln share offering at $34** On Mon, DFTX's stock soared 50% to $36.67 after co said its LSD-based drug, DT120,significantly reduced symptomsof major depression in patients in late-stage trial** After the bell Mon, counveiled$500 mln offering for R&D of its product candidates, preparation activities for potential commercialization of DT120, among other purposes** JP Morgan, Jefferies, Leerink and BofA joint lead bookrunners** Stock has more than tripled YTD** All 16 analysts covering the stock are bullish including 6 \"strong buy\" ratings; median PT $52, per LSEG data","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nL6N42W0VF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","LU0868494708.USD","DFTX","LU1280957306.USD","LU0787776722.HKD","IE00BJLML261.HKD","JPX","LU0859254822.USD","LU1974910355.USD","JPMO","JPO","LU2237443549.SGD","BK0090","LU2746668974.SGD","IE00BZ1G4Q59.USD","IE00BN8TJ469.HKD","LU0234572021.USD","LU2756315664.SGD","BK4516","LU0820562030.AUD","LU0211327993.USD","LU2462157665.USD","BK0010","LU0265550359.USD","LU1670628061.USD","LU2054465674.USD","BK4007","LU0345770308.USD","LU0320765646.SGD","LU2237443978.SGD","LU0203345920.USD","LU2505996681.GBP","600776","LU0256863902.USD","LU0976567544.SGD","LU1496350502.SGD","LU2023250330.USD","IE000M9KFDE8.USD","LU0070302665.USD","LU2505996509.AUD","LU1551013425.SGD","LU1917777945.USD","BK4550","IE00BLSP4452.SGD","LU2357305700.SGD","LU1119994496.HKD","LU1032466523.USD","LU0208291251.USD","LU2417539215.USD","LU0149725797.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645894309","title":"Definium Therapeutics 20.6M share Secondary priced at $34.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2645894309","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645894309?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:20","pubTimestamp":1782296419,"startTime":"0","endTime":"0","summary":"The deal size was increased to $700M in common stock from $500M in common stock. JPMorgan, Jefferies, Leerink and BofA acted as joint book running ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-20-6m-share-secondary-priced-at-34-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-20-6m-share-secondary-priced-at-34-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0203345920.USD","BK4534","LU0149725797.USD","LU0320765646.SGD","LU2552382215.SGD","LU2244417387.USD","LU2505996509.AUD","LU0265550359.USD","LU0106831901.USD","SG9999002232.USD","JPMO","IE0034235303.USD","LU0211327993.USD","IE00BWXC8680.SGD","DFTX","IE0034235188.USD","LU2505996681.GBP","LU1032466523.USD","LU0640476718.USD","LU1894683264.USD","JPO","PGF","IE00BLSP4452.SGD","LU0070302665.USD","JPX","LU0323591593.USD","LU0882574139.USD","LU1244550494.USD","LU1551013342.USD","LU0170899867.USD","LU1116320901.HKD","LU2213496289.HKD","BK4504","LU2106854487.HKD","LU2357305700.SGD","BK4533","IE00B1XK9C88.USD","LU0689472784.USD","LU0859254822.USD","LU0964807845.USD","LU1244550221.USD","LU1496350502.SGD","LU1974910355.USD","LU2242649171.HKD","LU2746668974.SGD","LU1280957306.USD","LU0267386448.USD","SG9999002224.SGD","LU0265550946.USD","LU2592432038.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645955468","title":"Definium Therapeutics price target raised to $74 from $61 at JonesResearch","url":"https://stock-news.laohu8.com/highlight/detail?id=2645955468","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645955468?lang=en_us&edition=fundamental","pubTime":"2026-06-24 16:40","pubTimestamp":1782290413,"startTime":"0","endTime":"0","summary":"JonesResearch raised the firm’s price target on Definium Therapeutics (DFTX) to $74 from $61 and keeps a Buy rating on the shares after the company...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-74-from-61-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-74-from-61-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645863005","title":"BRIEF-Definium Prices Offering Of 20.59 Million Shares At $34/Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2645863005","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645863005?lang=en_us&edition=fundamental","pubTime":"2026-06-24 09:58","pubTimestamp":1782266332,"startTime":"0","endTime":"0","summary":"BRIEF-Definium Prices Offering Of 20.59 Million Shares At $34/ShareJune 23 (Reuters) - Definium Therapeutics Inc DFTX.O:DEFINIUM THERAPEUTICS, INC. ANNOUNCES PRICING OF $700 MILLION UPSIZED PUBLIC OFF","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nTUABTBPTK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645006863","title":"Definium Therapeutics prices upsized public offering at USD 700 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2645006863","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645006863?lang=en_us&edition=fundamental","pubTime":"2026-06-24 09:57","pubTimestamp":1782266235,"startTime":"0","endTime":"0","summary":"Definium Therapeutics priced an upsized underwritten follow-on offering of 20,588,236 common shares at USD 34 per share.Gross proceeds expected to total about USD 700 million, before underwriting discounts, commissions, and offering expenses.Underwriters hold a 30-day option to buy up to 3,088,235 additional common shares at the offering price, less discounts and commissions.Net proceeds earmarked for R&D, pre-commercialization work for DT120 ODT if approved, working capital, and general corporate purposes.Closing targeted for about June 25, 2026, subject to customary conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire  o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDLbsVN9d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645863076","title":"Definium Therapeutics - Prices Public Offering of 20.59 Mln Shares at $34 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2645863076","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645863076?lang=en_us&edition=fundamental","pubTime":"2026-06-24 09:57","pubTimestamp":1782266220,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nTUABTBPTK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}